Open Text Corporation (NASDAQ: OTEX, TSX: OTEX) confirmed today that the nominees listed below were re-elected by shareholders at its annual meeting of shareholders (the "Meeting") held virtually ...
‘Upon completion of the acquisition, OpenText will be one of the world’s largest software and cloud businesses with a tremendous marquee customer base, global scale and comprehensive go-to ...
11, 2024 /CNW/ -- OpenText (NASDAQ: OTEX, TSX: OTEX) today announced it has received authorization for the OpenText IT Management Platform (ITMX) from the Federal Risk and Authorization Management ...
NEW YORK, Aug. 14, 2024 /PRNewswire/ -- Actuate, a leading innovator in computer vision technology for remote video guarding, proudly announces the successful closing of an $11.5 million funding ...
Open Text Corp. is an independent software company that provides software products and services that assist organizations in finding, utilizing, and sharing business information from any device.
OpenText said Wednesday it has acquired the Pillr managed detection and response (MDR) platform from cybersecurity services powerhouse Novacoast. The terms of the deal were not disclosed. The ...
Shares of Open Text Corp. OTEX inched 0.32% higher to C$43.33 Wednesday, in what proved to be an otherwise all-around negative trading session for the Canadian market, with the S&P/TSX Composite ...
Actuate Therapeutics has won Food and Drug Administration orphan-drug designation for its lead investigational drug product in a group of rare cancerous tumors. Actuate on Wednesday said the ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Elraglusib is a Class-LeadingGSK-3β Inhibitor with a Novel, Multimodal Mechanism of Action in Multiple Refractory Cancer Trials Orphan Drug Designation in Soft Tissue Sarcomas Expands Company’s ...